ReviewDiabetology & metabolic syndrome2025
Exercise training and inflammatory adipokines in patients with type 2 diabetes: a systematic review, meta-analysis, and meta-regression.
Review in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A combined model integrating adiponectin and anthropometric indices for the identification of insulin resistance in patients with type 2 diabetes mellitus.BMC endocrine disorders · 2026Article
- From Adipose Tissue to Endothelial Cells-Pleiotropic Role of Vaspin in Pathogenesis of Metabolic and Cardiovascular Diseases.Biomedicines · 2025Review
- Correction: Exercise training and infammatory adipokines in patients with type 2 diabetes: a systematic review, meta-analysis, and meta-regression.Diabetology & metabolic syndrome · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundImprovements in adipocytes levels can reduce the risk of diabetes and cardiovascular disease, indicating adipocytes to be a hopeful remedial target in type 2 diabetes mellitus (T2DM) and other related diseases. However, there is no consensus on the role of various exercise training on adipokines in T2DM and the results are contradictory. Therefore, this systematic review, meta-analysis, and meta-regression investigated the effects of different types of exercise training on some inflammatory adipokines concentrations in T2DM.
methodsA systematic search was conducted in PubMed/MEDLINE, Web of Science, Embase, Google Scholar, and Cochrane up to September 2024. Studies investigating the effects of exercise training on Resistin, apelin, visfatin, and vaspin were included. Meta-analysis was performed using a random-effect model (DerSimonian-Laird method) to calculate weighted means differences with 95% confidence intervals (CIs). The Cochrane Collaboration's tool was also used to asses risk of bias of studies.
resultsAnalysis of 36 studies (50 intervention arms, n = 1811) demonstrated that exercise training significantly decreased resistin (mean difference [MD]: -1.02 ng/ml, 95% CI -1.48 to -0.57, p < 0.0001) and visfatin (MD: -0.70 ng/ml, 95% CI -1.07 to -0.32, p = 0.0002) levels but had no significant effect on Apelin (MD: 0.02 ng/ml, 95% CI -0.04 to 0.08, p = 0.55) and vaspin (MD: 0.00 ng/ml, 95% CI -0.0 to 0.0, p = 0.69) levels compared to control in T2DM. Stronger effects were observed in combined training in men and more than 8 weeks of intervention. Meta-regression analysis also showed that there is a significant linear relation between changes in resistin with BMI changes but other variables were not observed to have significant linear relationships with changes of BMI, glucose, Insulin, and HOMA-IR.
conclusionsOverall, aerobic and combined training decreased inflammatory adipokines with a positive supplementary effect for patient with T2DM. REGISTRATION: PROSPERO registration no. CRD42024617538.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.